Skip to main content

Table 8 Summary of predictive power of compound variables on the outcome (death or release) for patients with and without diabetes and for the total sample

From: Diabetes related phenotypes and their influence on outcomes of patients with corona virus disease 2019 (COVID-19)

Compound

Area under the ROC curve

Total %

O.R

Total

variable

DM Group %

Non-DM group %

DM Group

Non-DM Group

SAPS3

72.60

75.20

74.50

0.0065

0.0002

0.0003

Adm PC 1

58.40

55.10

56.20

10.054

5.357

8.033

Adm PC 2

59.40

56.70

57.50

0.0924

0.155

0.108

INFLA PC 1

74.80

73.50

74.20

1.9 × 10–5

4.8 × 10–12

1.9 × 10–12

INFLA PC 2

69.90

70.70

71.00

8.9 × 10–4

1.6 × 10–10

1.1 × 10–11

COAG PC 1

58.30

61.50

60.10

0.0513

0.021

0.015

COAG PC 2

53.10

58.50

56.10

1.884

20.37

10.54

REN PC 1

71.10

63.40

66.80

2.7 × 10–4

0.027

0.026

REN PC 2

53.40

54.70

53.50

0.0565

0.115

0.186

  1. Adm PC1 and Adm PC2, INFLA PC 1 and INFLA PC 2, COAG PC 1 and COAG PC 2 and RENAL PC 1 and RENAL PC 2-comprised Principal Components (PC) of laboratory analyses related to admission, inflammatory, coagulation and renal status of patients
  2. DM, diabetes